Market key trends:
The head and neck cancer drugs market is witnessing high growth owing to rising prevalence of head and neck cancer worldwide. According to WHO, around 740,000 new cancer cases and around 400,000 cancer deaths are reported each year globally. Majority of cases occur in less developed regions where the disease is caught at later stages. Increasing adoption of targeted therapy drugs and development of combination therapies for achieving better cure rates is supporting the market growth. For instance, drugs used in combination with immunotherapy are showing promising results. Also, novel drug delivery methods such as nanoparticles are being explored by key players to enhance the therapeutic efficacy of drugs for improved patient outcomes. These factors are expected to drive robust growth of the global head and neck cancer drugs market over the forecast period.

Key Takeaways
The Global Head And Neck Cancer Drugs Market Size is expected to witness high growth, exhibiting CAGR of 7.3% over the forecast period, due to increasing prevalence of cancer worldwide. The market size for 2023 is US$ 1,986.3 Mn.

Read More: https://newsinsights123.blogspot.com/2023/11/immuno-oncology-drugs-segment-is.html